UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000022218 |
|---|---|
| Receipt number | R000025239 |
| Scientific Title | A randomized controlled trial of single-incision versus conventional multi-port laparoscopic gastrectomy for clinical stage I gastric cancer |
| Date of disclosure of the study information | 2016/05/09 |
| Last modified on | 2019/08/27 11:42:12 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A randomized controlled trial of single-incision versus conventional multi-port laparoscopic gastrectomy for clinical stage I gastric cancer
Acronym
A randomized trial of SLG vs. MLG for clinical stage I gastric cancer
Scientific Title
A randomized controlled trial of single-incision versus conventional multi-port laparoscopic gastrectomy for clinical stage I gastric cancer
Scientific Title:Acronym
A randomized trial of SLG vs. MLG for clinical stage I gastric cancer
Region
| Japan |
Condition
Condition
Gastric cancer
Classification by specialty
| Gastrointestinal surgery |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the safety and efficacy of single-incision laparoscopic gastrectomy compared to conventional multi-port laparoscopic gastrectomy for clinical stage I gastric cancer
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Phase II
Assessment
Primary outcomes
Degree of postoperative pain
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Open -no one is blinded
Control
Active
Stratification
Dynamic allocation
YES
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Treatment
Type of intervention
| Maneuver |
Interventions/Control_1
Single-incision laparoscopic gastrectomy
Interventions/Control_2
Multi-port laparoscopic gastrectomy
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 80 | years-old | > |
Gender
Male and Female
Key inclusion criteria
(1) Histologically confirmed gastric adenocarcinoma.
(2) Indication of distal gastrectomy.
(3) c Stage I gastric cancer.
(4) No invasion to the duodenum
(5) Body mass index <30.
(6) Written informed consent.
Key exclusion criteria
(1) Synchronous or metachronous (within 5 years) malignancies other than carcinoma in situ.
(2) Women during pregnancy or breast-feeding.
(3) Severe mental disease.
(4) Continuous systemic steroid therapy.
(5) History of myocardial infarction or unstable angina pectoris within six months.
(6) Uncontrollable hypertension.
(7) Uncontrollable diabetes millutus.
(8) Severe respiratory disease requiring continuous oxygen therapy.
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Takeshi Omori |
Organization
Osaka Medical Center for Cancer and Cardiovascular Diseases
Division name
Gastroenterological Surgery
Zip code
Address
1-3-3 Nakamichi, Higashinari-ku, Osaka, Japan
TEL
+81669721181
oomori-ta@mc.pref.osaka.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Takeshi Omori |
Organization
Osaka Medical Center for Cancer and Cardiovascular Diseases
Division name
Gastroenterological Surgery
Zip code
Address
1-3-3 Nakamichi, Higashinari-ku, Osaka, Japan
TEL
+81669721181
Homepage URL
oomori-ta@mc.pref.osaka.jp
Sponsor or person
Institute
Osaka Medical Center for Cancer and Cardiovascular Diseases
Institute
Department
Personal name
Funding Source
Organization
Osaka Medical Center for Cancer and Cardiovascular Diseases
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
大阪府立成人病センター
Other administrative information
Date of disclosure of the study information
| 2016 | Year | 05 | Month | 09 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2015 | Year | 09 | Month | 30 | Day |
Date of IRB
| 2016 | Year | 02 | Month | 17 | Day |
Anticipated trial start date
| 2016 | Year | 05 | Month | 09 | Day |
Last follow-up date
| 2021 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2016 | Year | 05 | Month | 06 | Day |
Last modified on
| 2019 | Year | 08 | Month | 27 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025239
